GeneBioTech Co. Ltd (086060) — Capital Reinvestment Ratio
GeneBioTech Co. Ltd (086060) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.87 Billion) in capital expenditures (₩194.03 Million). See GeneBioTech Co. Ltd (086060) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GeneBioTech Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks GeneBioTech Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check GeneBioTech Co. Ltd (086060) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for GeneBioTech Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for GeneBioTech Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see GeneBioTech Co. Ltd (086060) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | ₩7.37 Billion | ₩766.93 Million | ▼ -94.1% |
| 2020 | 1.76x | ₩2.49 Billion | ₩4.39 Billion | ▲ +1777.2% |
| 2018 | 0.09x | ₩5.96 Billion | ₩558.47 Million | ▼ -90.4% |
| 2017 | 0.98x | ₩1.13 Billion | ₩1.11 Billion | ▲ +300.8% |
| 2016 | 0.24x | ₩5.31 Billion | ₩1.30 Billion | ▼ -31.5% |
| 2015 | 0.36x | ₩2.61 Billion | ₩927.06 Million | ▲ +50.2% |
| 2014 | 0.24x | ₩2.15 Billion | ₩510.55 Million | ▼ -3.2% |
| 2013 | 0.24x | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩2.68 Billion | ₩229.99 Million | — |